Stéphanie Forté: New Evidence Strengthens the Case for Hydroxyurea in HbSC Disease
Stéphanie Forté, Principal Researcher at the Innovation Hub at the CHUM Research Center (CRCHUM), shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in British Journal of Haematology, adding:
”Our Quebec study on hydroxyurea in SC disease (HbSC) has just been the subject of an editorial commentary in the British Journal of Haematology.
The message of the commentary is clear: HbSC disease is not a ‘mild’ form of sickle cell disease — it is a biologically distinct entity, long understudied and undertreated out of an abundance of caution.
Our results show a 56 percent reduction in vaso-occlusive crises with hydroxyurea initiation, without complications related to hyperviscosity — a historical fear in this population.
Interestingly, treatment discontinuations were mostly related to modifiable barriers (prescription renewal, education, follow-up) rather than toxicity.
A reminder that patient support is as important as pharmacology.”
Title: Hydroxyurea (hydroxycarbamide) use in adults with haemoglobin SC disease: A real-world study in Quebec
Authors: Alice Girard, Laurianne Charette, Mélissa Haouchine, Laurence Bozec, Mohamed Zakaria Bachir Bouyadjera, Mariane Poitras, Vincent-Thierry Taillefer, Chloé Trudeau, Yves Pastore, Nathalie Letarte, Stéphanie Forté

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 13, 2026, 16:17Shailendra Singh: Bombay Hospital Jaipur Inaugurates New Facility with Voluntary Blood Donation Camp
-
Nov 13, 2026, 16:10Minka Zivkovic: UMC Utrecht Announces Research Analyst Vacancy in Thrombosis and Haemostasis
-
Nov 13, 2026, 16:02Rounak Dubey: Elsevier’s Upcoming Handbook Explores Digitalization in Transfusion Medicine
-
Nov 13, 2026, 15:50Maha Othman: CanVECTOR 2026 Highlights Research on Immunothrombosis and Cancer-Associated Thrombosis
-
Nov 13, 2026, 15:48Cedric Hermans: Advances in Gene Therapy for Haemophilia A
-
Nov 13, 2026, 15:45Strengthens Global Collaboration in Thrombosis and Hemostasis for 2027 – ISTH
-
Nov 13, 2026, 15:42David McIntosh: The Global Blood Shortage Crisis and the Urgent Need for National Action
-
Nov 13, 2026, 15:41JTH Highlights Future Directions in Thromboprophylaxis for Hospitalized Children
-
Nov 13, 2026, 15:21Wolfgang Miesbach։ Gene Therapy for Haemophilia B Is Cheaper Than Lifelong Factor IX Prophylaxis in Sweden